128 related articles for article (PubMed ID: 35689862)
1. FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
Crivelli SM; Luo Q; Kruining DV; Giovagnoni C; Mané-Damas M; den Hoedt S; Berkes D; De Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Wijnands EPM; Bieberich E; Losen M; Martinez-Martinez P
Biomed Pharmacother; 2022 Aug; 152():113240. PubMed ID: 35689862
[TBL] [Abstract][Full Text] [Related]
2. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
3. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease.
Lin AL; Parikh I; Yanckello LM; White RS; Hartz AMS; Taylor CE; McCulloch SD; Thalman SW; Xia M; McCarty K; Ubele M; Head E; Hyder F; Sanganahalli BG
Neurobiol Dis; 2020 Jun; 139():104834. PubMed ID: 32173556
[TBL] [Abstract][Full Text] [Related]
4. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
[TBL] [Abstract][Full Text] [Related]
7. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Wójtowicz S; Strosznajder J; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
[TBL] [Abstract][Full Text] [Related]
8. ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.
Bandaru VV; Troncoso J; Wheeler D; Pletnikova O; Wang J; Conant K; Haughey NJ
Neurobiol Aging; 2009 Apr; 30(4):591-9. PubMed ID: 17888544
[TBL] [Abstract][Full Text] [Related]
9. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain.
Teter B; LaDu MJ; Sullivan PM; Frautschy SA; Cole GM
Neuroreport; 2016 Aug; 27(11):791-5. PubMed ID: 27281274
[TBL] [Abstract][Full Text] [Related]
11. Ceramide analog [
Crivelli SM; van Kruining D; Luo Q; Stevens JAA; Giovagnoni C; Paulus A; Bauwens M; Berkes D; de Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Mottaghy FM; Losen M; Bieberich E; Martinez-Martinez P
Sci Rep; 2020 Nov; 10(1):19354. PubMed ID: 33168861
[TBL] [Abstract][Full Text] [Related]
12. CERT
Crivelli SM; Luo Q; Stevens JAA; Giovagnoni C; van Kruining D; Bode G; den Hoedt S; Hobo B; Scheithauer AL; Walter J; Mulder MT; Exley C; Mold M; Mielke MM; De Vries HE; Wouters K; van den Hove DLA; Berkes D; Ledesma MD; Verhaagen J; Losen M; Bieberich E; Martinez-Martinez P
Alzheimers Res Ther; 2021 Feb; 13(1):45. PubMed ID: 33597019
[TBL] [Abstract][Full Text] [Related]
13. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.
Youmans KL; Tai LM; Nwabuisi-Heath E; Jungbauer L; Kanekiyo T; Gan M; Kim J; Eimer WA; Estus S; Rebeck GW; Weeber EJ; Bu G; Yu C; Ladu MJ
J Biol Chem; 2012 Dec; 287(50):41774-86. PubMed ID: 23060451
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
[TBL] [Abstract][Full Text] [Related]
16. Estradiol improves behavior in FAD transgenic mice that express
Balu D; Valencia-Olvera AC; Deshpande A; Narayanam S; Konasani S; Pattisapu S; York JM; Thatcher GRJ; LaDu MJ; Tai LM
Front Endocrinol (Lausanne); 2024; 15():1374825. PubMed ID: 38742194
[TBL] [Abstract][Full Text] [Related]
17. Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells.
Kurano M; Tsukamoto K; Sakai E; Hara M; Yatomi Y
J Alzheimers Dis; 2022; 85(4):1529-1544. PubMed ID: 34958030
[TBL] [Abstract][Full Text] [Related]
18. APOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease.
Taxier LR; Philippi SM; Fleischer AW; York JM; LaDu MJ; Frick KM
Neurobiol Aging; 2022 Oct; 118():13-24. PubMed ID: 35843109
[TBL] [Abstract][Full Text] [Related]
19. APOE4 genotype or ovarian hormone loss influence open field exploration in an EFAD mouse model of Alzheimer's disease.
Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM
Horm Behav; 2022 Apr; 140():105124. PubMed ID: 35101701
[TBL] [Abstract][Full Text] [Related]
20. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
